What would you do if you lived in a place where the power supply was …
Read More »Eli Lilly says GLP
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for diabetes and weight loss. The trial of the drug, orforglipron, measured its efficacy and safety in …
Read More »



